<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>54</viewCount><searchCount>0</searchCount></scores><additional><submitter>Hoffmann J</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>European Research Council</funding><pagination>3964</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8233308</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the bone vascular cell composition. We demonstrate an age-independent loss of type H endothelium in heart failure after myocardial infarction in both mice and humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium, showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Endothelial-specific overexpression of MYC was sufficient to induce type H bone endothelial cells, whereas inhibition of NLRP3-dependent IL-1β production partially prevented the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of bone vascular function in ischemic heart disease.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Post-myocardial infarction heart failure dysregulates the bone vascular niche.</pubmed_title><pmcid>PMC8233308</pmcid><funding_grant_id>SFB 834 - B1</funding_grant_id><funding_grant_id>773047</funding_grant_id><funding_grant_id>SFB 834 - B6</funding_grant_id><pubmed_authors>Abplanalp WT</pubmed_authors><pubmed_authors>Assmus B</pubmed_authors><pubmed_authors>Muhly-Reinholz M</pubmed_authors><pubmed_authors>Fischer A</pubmed_authors><pubmed_authors>Hoffmann J</pubmed_authors><pubmed_authors>Glaser SF</pubmed_authors><pubmed_authors>Rasper T</pubmed_authors><pubmed_authors>Potente M</pubmed_authors><pubmed_authors>Dimmeler S</pubmed_authors><pubmed_authors>Luxan G</pubmed_authors><pubmed_authors>Zeiher AM</pubmed_authors><pubmed_authors>John D</pubmed_authors><view_count>54</view_count></additional><is_claimable>false</is_claimable><name>Post-myocardial infarction heart failure dysregulates the bone vascular niche.</name><description>The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the bone vascular cell composition. We demonstrate an age-independent loss of type H endothelium in heart failure after myocardial infarction in both mice and humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium, showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Endothelial-specific overexpression of MYC was sufficient to induce type H bone endothelial cells, whereas inhibition of NLRP3-dependent IL-1β production partially prevented the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of bone vascular function in ischemic heart disease.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2024-10-17T20:51:50.594Z</modification><creation>2022-02-10T18:33:24.904Z</creation></dates><accession>S-EPMC8233308</accession><cross_references><pubmed>34172720</pubmed><doi>10.1038/s41467-021-24045-4</doi></cross_references></HashMap>